Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata is an autoimmune disease causing hair loss, linked to immune and gut issues, needing more research for better treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

ceRNA networks offer potential treatments for skin aging and wound healing.

Hair melanocytes help the skin respond to stress and regulate hair pigmentation.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Hair follicle stem cells and their exosomes help repair nerve injuries.

Hair follicle stem cells and their exosomes help repair nerve injuries.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Targeting Midkine can help reduce pain and itching in keloids.

TGF-β and FGF pathways are crucial for skin development and regeneration.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Cell adhesion molecules are important in the development of certain skin diseases.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Diet and lifestyle changes can help manage autoimmune diseases by reducing inflammation and supporting immune health.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

mTOR may link different pathways in hair follicle tumor formation.

More precise, personalized therapies are needed for autoimmune diseases.